Unreported antiretroviral use by HIV-1-infected participants enrolling in a prospective research study

J Acquir Immune Defic Syndr. 2014 Feb 1;65(2):e90-4. doi: 10.1097/QAI.0b013e3182a2db02.

¹ *Department of Epidemiology, University of Washington, Seattle, WA †Division of Pharmacotherapy and Experimental Therapeutics, Echelman School of Pharmacy, University of North Carolina, Chapel Hill, NC Departments of ‡Global Health; §Medicine, University of Washington, Seattle, WA ‖Department of Medicine, Indiana University, Indianapolis, IN ¶Department of Immunology and Infectious Disease, Harvard School of Public Health, Harvard University, Cambridge, MA #Perinatal HIV Research Unit, University of Witwatersrand, Johannesburg, Republic of South Africa **Vaccine and Infectious Disease Institute, Fred Hutchinson Cancer Research Center, Seattle, WA ††Department of Pediatrics, University of Washington, Seattle, WA ‡‡Wits Reproductive Health and HIV Institute, University of Witwatersrand, Johannesburg, Republic of South Africa §§Department of Obstetrics and Gynecology, University of Nairobi and Kenyatta National Hospital, Nairobi, Kenya.

No abstract available

Publication types